These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1974493)

  • 1. Tolerance to oral H2-receptor antagonists.
    Wilder-Smith CH; Ernst T; Gennoni M; Zeyen B; Halter F; Merki HS
    Dig Dis Sci; 1990 Aug; 35(8):976-83. PubMed ID: 1974493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection.
    Komazawa Y; Adachi K; Mihara T; Ono M; Kawamura A; Fujishiro H; Kinoshita Y
    J Gastroenterol Hepatol; 2003 Jun; 18(6):678-82. PubMed ID: 12753150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.
    Merki HS; Halter F; Wilder-Smith CH
    Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine suspension or famotidine resoriblette and gastric fluid volume and pH.
    Oikkonen M; Erkola O; Collan R
    Can J Anaesth; 1995 Sep; 42(9):793-6. PubMed ID: 7497560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
    Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of acid suppression during dosing with H2-receptor antagonists.
    Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
    Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
    Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer.
    Wilder-Smith CH; Halter F; Merki HS
    Dig Dis Sci; 1991 Dec; 36(12):1685-90. PubMed ID: 1748035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
    Ley LM; Becker A; Lühmann R; Sander P; Lücker PW
    Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
    Katsu K; Yabe S
    Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of low doses of ranitidine on intragastric acidity in healthy men.
    Wyeth JW; Pounder RE; Sercombe JC; Snell CC
    Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.